NovoLog (Page 8 of 8)

PRINCIPAL DISPLAY PANEL — 3 mL NovoLog FlexPen

NDC 68258-8899-03

NovoLog^® FlexPen^®

Prefilled Syringe

Insulin aspart Injection (rDNA origin)

100 units/mL (U-100)

5 x 3 mL Prefilled Insulin Syringes

Rx only

Single patient use only

For use with NovoFine^® disposable needles.

Keep in a cold place. Avoid freezing.

Protect from light.

NOVOLOG insulin aspart injection, solution

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68258-8899(NDC:0169-6339) Route of Administration INTRAVENOUS, SUBCUTANEOUS DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength INSULIN ASPART (INSULIN ASPART) INSULIN ASPART 100 [iU] in 1 mL

Inactive Ingredients Ingredient Name Strength SODIUM PHOSPHATE, DIBASIC, DIHYDRATE 1.25 mg in 1 mL GLYCERIN 16 mg in 1 mL HYDROCHLORIC ACID METACRESOL 1.72 mg in 1 mL PHENOL 1.5 mg in 1 mL SODIUM CHLORIDE 0.58 mg in 1 mL SODIUM HYDROXIDE ZINC 19.6 ug in 1 mL

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:68258-8899-3 3 mL in 1 SYRINGE, PLASTIC None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020986 01/22/2003

Labeler — Dispensing Solutions, Inc. (066070785)

Registrant — PSS World Medical, Inc. (101822682)

Establishment
Name	Address	ID/FEI	Operations
Dispensing Solutions, Inc.		066070785	relabel (68258-8899), repack (68258-8899)

Revised: 07/2013 Dispensing Solutions, Inc.